Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
about
Galactic cosmic radiation leads to cognitive impairment and increased aβ plaque accumulation in a mouse model of Alzheimer's diseasePredicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomographyRole of imaging techniques in the diagnosis of dementiaTranslatability scoring in drug development: eight case studiesHuman brain myelination and amyloid beta deposition in Alzheimer's disease11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementiaAlzheimer disease: new concepts on its neurobiology and the clinical role imaging will playThe episodic memory system: neurocircuitry and disordersMR-less surface-based amyloid assessment based on 11C PiB PETPlaque and tangle imaging and cognition in normal aging and Alzheimer's diseaseMild cognitive impairment: pathology and mechanisms.Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) depositionAmyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairmentProtein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseasesBiomarkers of Alzheimer's diseaseActive and passive immunotherapy for neurodegenerative disordersMild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's DiseaseUntangling tau imagingA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersToward precision medicine in Alzheimer's diseaseWhat can imaging tell us about cognitive impairment and dementia?The amyloid hypothesis of Alzheimer's disease at 25 yearsInsight into the Molecular Imaging of Alzheimer's DiseaseAmyloid positron emission tomography and cognitive reserveImaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence ImagingNeuroimaging assessment of early and late neurobiological sequelae of traumatic brain injury: implications for CTEMild Neurocognitive Disorder: An Old Wine in a New BottleRole of HIV in amyloid metabolismAlzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkersThe relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associationsShift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventionsEarly failure of the default-mode network and the pathogenesis of Alzheimer's diseasePotential of functional MRI as a biomarker in early Alzheimer's diseaseNeuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureExplaining the encoding/retrieval flip: memory-related deactivations and activations in the posteromedial cortexAcute and chronic traumatic encephalopathies: pathogenesis and biomarkers.Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals
P2860
Q21133775-2F548E0C-AAE9-4945-B076-807FC5A17093Q21146623-4F7324C6-9B35-4BA5-A833-39D9DC62A958Q22241579-40651620-EDD5-45EB-8F65-D1C8751D9A71Q22241760-ABDD11CC-26CF-485D-86F3-748501B46BDEQ22252428-EB35F708-1181-416B-ADC2-22B5F8323375Q24194742-602CF6D4-FF8F-45F9-BE28-515B25F87F22Q24201039-AFCCC089-D7D3-496D-A0AB-1DDC3AEF5C0FQ24235058-C2B7D0C3-F29E-4DE1-B4F8-872BB6BDE2B1Q24594531-78E3A277-2285-454A-908B-907F5F1A5863Q24596449-08C5EC22-35DB-4355-A11F-274408040731Q24618963-266D15D3-10A1-44A9-B8D6-E22080F2BFB7Q24629601-7A99A4E1-6177-4B6D-86FC-E320742C63E8Q24631255-D21BD407-284B-4A92-B92F-30F4E62DB4D4Q24631814-2F8B98C0-7A27-4DB0-B190-F777E594DF2CQ24648007-DC5B47B5-A28E-44D0-A165-CDC8F5BE9D14Q24648319-1DD6730D-F1EE-41E0-B309-89398786733FQ24650014-630455EA-3F98-49CB-B231-744A7A4DA963Q24650667-4FCBDC6F-0B5E-4E67-935D-7E8632E021A6Q24657879-CE508A2B-5352-422A-A3C3-8209D1CFC947Q24678457-51E202F1-1478-430B-B203-B4AA95E8CC4FQ26739091-AEB05C34-5250-4A00-82E2-4399D810AC94Q26745508-D1B9E679-6045-4C21-9B83-AFAD29A98939Q26748939-0AAA5960-A71A-4747-87AE-8337D92C1428Q26749292-DEF4F3D4-879B-4104-9828-698DE8D835B7Q26749528-EAF340D0-18F7-4719-856A-52717CB87553Q26765945-8E674D86-5EFE-4C58-AB36-BB4BD1FE6E44Q26769755-41E6E49D-05C2-47EE-A0C0-ED6F0FAE3C6EQ26770766-BF2B94B7-073D-46B2-8E87-EB1B0F75D861Q26781672-677356E3-B111-452E-81A8-8421C019FED3Q26786539-E1025A19-57A9-41FB-BFFD-E2C3AE7334F0Q26824179-75A71097-9CD7-424E-9411-D4FAEF4F316FQ26825442-F50BB5F8-C364-4865-ACD2-24590D8734C8Q26830467-EE14BDBE-967E-4663-B413-98C2EB2EBFEAQ26830740-B0041BE1-F191-4A49-82CD-1BE526E8FD83Q26862463-DD1AFC49-4FF0-470B-9406-8A9A785196D7Q26864734-E8B1A545-FACB-49BF-9EBC-407BC3BE4D6DQ26864905-CBB6F23D-3EF4-4078-9321-9B834199E68EQ26866075-A8C67D3B-CE66-4020-B8C8-2A903D461B06Q26995259-F6EF6264-2A29-409E-971E-1920D0F76826Q26995405-842C3C58-FF3A-4A01-B3A3-5F6D1611F794
P2860
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
@ast
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
@en
type
label
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
@ast
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
@en
prefLabel
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
@ast
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
@en
P2093
P50
P3181
P356
P1433
P1476
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
@en
P2093
Anders Wall
Birgitta Ausén
Brian J. Lopresti
Chester A. Mathis
Daniel P. Holt
Gunnar Antoni
Gunnar Blomqvist
Guo-Feng Huang
Henry Engler
Irina Savitcheva
P304
P3181
P356
10.1002/ANA.20009
P577
2004-01-21T00:00:00Z